Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Pliant Therapeutics, Inc. (PLRX)

NASDAQ

$1.17

$+0.04

(+3.10%)

Previous Close: ⁦$1.13⁩

Market Closed

Pliant Therapeutics, Inc. (PLRX) Live Price Chart

Last updated: ⁦2026-09-06 15:08:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Pliant Therapeutics, Inc. (PLRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.17, with a market capitalization of $71.83M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.02 to $1.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$71.83M
Open	$1.12
Day's High	$43.92
Day's Low	$1.02
Previous Close	$1.13
Volume	544.71K
Average Volume	--
P/E Ratio	--
52-Week High	$1.95
52-Week Low	$1.02
Dividend Yield	--
Earnings Date	--

Pliant Therapeutics, Inc. (PLRX) Latest Closing Stock Price

Pliant Therapeutics, Inc. (PLRX) last closed at $1.13 as of 2026-09-04 23:31:00, unchanged from the previous close of $1.13.

During the latest regular trading session, PLRX traded between $1.02 and $43.92, with a volume of 544.71K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Pliant Therapeutics, Inc. (PLRX) 7-Day Stock Price Change

Over the past seven days, Pliant Therapeutics, Inc. (PLRX) moved from $1.10 to $1.17, representing a gain of 5.91% ($0.06).

The stock traded between $1.11 and $1.18 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 373.24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PLRX 52-Week Price Position

Position in Range: 15.6%

52W Low$1.02

52W High$1.95

PLRX is currently trading at $1.17, placing it 15.6% of the way from its 52-week low of $1.02 to its 52-week high of $1.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pliant Therapeutics, Inc. (PLRX)?

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Pliant Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	49
Exchange	NASDAQ
Company Website	https://www.pliantrx.com

How to Buy Pliant Therapeutics, Inc. (PLRX) Stock on MEXC

Eligible investors can buy real shares of Pliant Therapeutics, Inc. (PLRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PLRX and Place Your Order

Open the RealStocks trading page and search for PLRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pliant Therapeutics, Inc. (PLRX) stock price today?

Pliant Therapeutics, Inc. (PLRX) is currently trading at $ 1.17, up 3.10% ($0.04) from the previous close of $ 1.13. Intraday prices update in real time during regular trading hours.

2.Is PLRX stock going up or down today?

As of 2026-09-04 23:31:00, PLRX is trading at $ 1.17, up 3.10% ($0.04) from its previous close of $ 1.13. The stock has traded between $ 1.02 and $ 43.92 during today’s regular session. Past price movements do not guarantee future results.

3.What is PLRX pre-market price?

As of 2026-09-04 23:31:00, PLRX is trading at $ 1.13 in pre-market trading, unchanged from the previous close of $ 1.13. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PLRX after-hours price?

As of 2026-09-04 23:31:00, PLRX is trading at $ 1.16 in after-hours trading, up 2.21% ($0.03) from the regular-session close of $ 1.13. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PLRX stock trading now?

PLRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PLRX sit relative to its 52-week high and low?

Over the past 52 weeks, PLRX has traded between a low of $ 1.02 and a high of $ 1.95. At $ 1.17, the stock is positioned 15.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pliant Therapeutics, Inc. in?

Pliant Therapeutics, Inc. (PLRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pliant Therapeutics, Inc.'s market capitalization and where is it listed?

Pliant Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 71.83M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PLRX valued in terms of P/E ratio and EPS?

PLRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.49. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pliant Therapeutics, Inc. pay a dividend?

Pliant Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.